Healthcare / Medical Care FacilitiesMexico
$61.90
+1.50 (+2.48%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $525.8M · quality 72.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
66/100
B
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$5.7B
P/E
12.4x
↓EV/EBITDA
5.6x
↓ROE
21.4%
↑Gross Margin
35.8%
↓Debt/Equity
0.40
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+7.4%
FCF CAGR
+45.2%
FCF margin
16.8%
FCF / Net income
1.49x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.79B · net income $540.2M · FCF $802.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.79B | $4.79B | $4.40B | $4.13B | $3.87B |
| Net Income | $540.2M | $540.2M | $461.5M | $635.0M | $949.8M |
| EBITDA | $1.11B | $1.11B | $863.9M | $995.5M | $922.8M |
| EPS | 5.00 | 5.00 | 4.30 | 5.88 | 8.80 |
| Gross Margin | 35.8% | 35.8% | 33.9% | 35.3% | 35.3% |
| Operating Margin | 16.8% | 16.8% | 12.9% | 14.3% | 14.9% |
| Net Margin | 11.3% | 11.3% | 10.5% | 15.4% | 24.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.40 | 0.40 | 0.44 | 0.51 | 0.41 |
| Current Ratio | 1.69 | 1.69 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $802.8M | $802.8M | $525.8M | $429.2M | $262.2M |
| Returns | |||||
| ROE | 21.4% | 21.4% | 19.7% | 31.2% | 37.7% |
| Valuation | |||||
| P/E | 12.38 | 12.38 | 7.86 | 6.91 | 4.32 |
| EV/EBITDA | 5.55 | 5.55 | 4.09 | 4.73 | 4.24 |
| P/B | 2.65 | 2.65 | 1.55 | 2.15 | 1.63 |
| Growth & Yield | |||||
| Revenue Growth | 8.8% | 8.8% | 6.6% | 6.8% | — |
| EPS Growth | 16.3% | 16.3% | -26.9% | -33.2% | — |
| Dividend Yield | 2.6% | 2.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
3.2%
EPS terminal req.
$5.49
Spread vs growth
13.1%
5Y implied EPS CAGR
5.9%
EPS terminal req.
$6.65
Spread vs growth
10.4%
10Y implied EPS CAGR
7.9%
EPS terminal req.
$10.70
Spread vs growth
8.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+43.5%
Start / end P/E
10.2x → 12.4x
EPS bridge
4.30 → 5.00
Residual
+3.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.